Non-Coding RNA Assays Market Players:
- Thermo Fisher Scientific Company
- Company Overview
- Business Strategy
- Key Product Offerings
- Financial Performance
- Key Performance Indicators
- Risk Analysis
- Recent Development
- Regional Presence
- SWOT Analysis
- Springer Nature Limited
- Applied Microarrays Inc.
- C D Genomics
- RELX Group
- MilliporeSigma
- QIAGEN
- Agilent Technologies, Inc.
- Danaher Corporation
- Eppendorf SE
Browse key industry insights with market data tables & charts from the report:
Frequently Asked Questions (FAQ)
In the year 2026, the industry size of non-coding RNA assays is estimated at USD 432.46 million.
The global non-coding RNA assays market size was more than USD 382.84 million in 2025 and is anticipated to grow at a CAGR of over 14.4%, reaching USD 1.47 billion revenue by 2035.
By 2035, North America is projected to secure a 40% share in the Non-Coding RNA Assays Market, supported by the strong presence of biotechnology and pharmaceutical companies.
Key players in the market include Thermo Fisher Scientific Company, Springer Nature Limited, Applied Microarrays Inc., C D Genomics, RELX Group, MilliporeSigma, QIAGEN, Agilent Technologies, Inc., Danaher Corporation, Eppendorf SE.